Formela Jean Francois (CIK 0001030575)

Latest company ownership

Shares held
238,034
Last filed at
Oct 24, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q1 2025Q4
IMA - ImageneBio, Inc.
Role: Director
Shares held
17,520
Last filed at
Jun 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
7,688
Last filed at
Jun 16, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
7,500
Last filed at
Aug 18, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 30, 2021 Dec 14, 2021 ImageneBio, Inc. Director Buy 87.5 +98,722 2.18% ✗ $1.6M
Jun 28, 2021 Jun 29, 2021 Intellia Therapeutics, Inc. Director Sell 2.5 -553,376 -98.22% ✓ $73.4M
Jun 11, 2021 Jun 15, 2021 Intellia Therapeutics, Inc. Director Sell 12.5 -201,725 -15.18% ✓ $17.6M
Apr 29, 2021 Apr 30, 2021 Intellia Therapeutics, Inc. Director Sell 45.0 -4,513 -0.59% ✓ $385.5K
Apr 26, 2021 Apr 28, 2021 Intellia Therapeutics, Inc. Director Sell 2.5 -342,962 -30.83% ✓ $29.5M
Apr 5, 2021 Apr 7, 2021 Intellia Therapeutics, Inc. Director Sell 51.3 -800 -0.07% ✓ $68K
Feb 26, 2021 Mar 1, 2021 Intellia Therapeutics, Inc. Director Sell 15.0 -501,945 -31.07% ✗ $30.3M
Jul 16, 2018 Jul 18, 2018 Intellia Therapeutics, Inc. Director Sell 10.0 -6,686 -100.00% ✓ $208.4K
Jun 19, 2018 Jun 20, 2018 Intellia Therapeutics, Inc. Director Sell 10.0 -6,686 -100.00% ✓ $186.9K
May 16, 2018 May 17, 2018 Intellia Therapeutics, Inc. Director Sell 10.0 -6,686 -100.00% ✓ $167.4K
Mar 20, 2018 Mar 22, 2018 Intellia Therapeutics, Inc. Director Sell 20.0 -39,245 -100.00% ✗ $936.7K
Nov 6, 2017 Nov 7, 2017 Spero Therapeutics, Inc. Director Buy 100.0 +428,571 21.65% ✗ $6M
Jul 7, 2017 Jul 11, 2017 Intellia Therapeutics, Inc. Director Sell 17.5 -150,000 -4.02% ✗ $2.4M
Mar 9, 2017 Mar 13, 2017 Intellia Therapeutics, Inc. Director Sell 20.0 -21,132 -100.00% ✗ $293.8K
Mar 29, 2010 Mar 31, 2010 Oruka Therapeutics, Inc. Director Sell 17.5 -140,000 -9.47% ✗ $1.1M